What are the diagnostic criteria and treatment options for pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Pulmonary Embolism

The diagnosis of pulmonary embolism requires a structured, sequential approach based on clinical probability assessment, D-dimer testing in appropriate patients, and confirmatory imaging with CT pulmonary angiography (CTPA) as the preferred modality. 1

Initial Clinical Assessment and Risk Stratification

Determine hemodynamic stability first—this dictates your entire diagnostic pathway. 2

  • High-risk PE (hemodynamically unstable): Defined by shock or systolic blood pressure <90 mmHg; requires immediate bedside echocardiography if CT is unavailable, and treatment should not be delayed for imaging 2
  • Non-high-risk PE (hemodynamically stable): Proceed with structured clinical probability assessment using validated tools like Wells score or structured clinical judgment 3, 2

The European Society of Cardiology recommends either a three-level scheme (low, intermediate, high probability) or two-level scheme (PE unlikely vs. PE likely) for clinical probability assessment 2

D-Dimer Testing Strategy

Only measure D-dimer in patients with low or intermediate clinical probability, or those classified as "PE unlikely"—never order it in high clinical probability patients. 2

  • A negative D-dimer (<500 ng/mL) in low/intermediate probability patients safely excludes PE without further testing, with 3-month thromboembolic risk below 1% 4, 3, 2
  • Consider age-adjusted cutoffs (age × 10 ng/mL in patients >50 years) to improve specificity 4
  • If D-dimer is elevated, proceed directly to imaging 3, 2

Special Rule-Out Criteria

Apply the Pulmonary Embolism Rule-Out Criteria (PERC) in patients with low clinical probability—if all 8 PERC criteria are met, no further testing is needed 3

Imaging Modalities for Confirmation

CT Pulmonary Angiography (First-Line)

CTPA is the imaging test of first choice and should be performed in patients with elevated D-dimer or high clinical probability. 3, 2

  • Accept the diagnosis of PE if CTPA shows a segmental or more proximal filling defect 1, 2
  • A normal multidetector CT (MDCT) alone safely excludes PE in patients with non-high clinical probability 1
  • Single-detector CT (SDCT) requires additional compression ultrasonography (CUS) of lower extremities due to lower sensitivity 1
  • Reject the diagnosis without further testing if CTPA is normal in patients with low or intermediate clinical probability 4

Ventilation-Perfusion (V/Q) Scintigraphy (Alternative)

V/Q scanning is a valid option when CTPA is contraindicated (renal failure, contrast allergy, pregnancy with normal chest X-ray) 1, 3

  • A normal perfusion scan definitively excludes PE without further testing 4, 2
  • A high-probability V/Q scan confirms PE in patients with high clinical probability 1, 3
  • Non-diagnostic scans (low or intermediate probability) combined with low clinical probability and negative proximal CUS can exclude PE 1

Compression Ultrasonography

Finding a proximal deep vein thrombosis (DVT) on CUS is sufficient to warrant anticoagulation without further testing for PE 1

  • CUS shows DVT in 30-50% of patients with PE 1
  • Particularly useful before CT in patients with contraindications to contrast (renal failure, allergy) to potentially avoid CT altogether 1
  • Mandatory when using single-detector CT due to its lower sensitivity 1

Pulmonary Angiography (Gold Standard)

Pulmonary angiography remains the reference standard but should be reserved for patients in whom non-invasive tests remain indeterminate 1

  • Direct angiographic signs include complete vessel obstruction with concave border or filling defect 1
  • Sensitivity and specificity both range from 95-98% 1

Validated Diagnostic Criteria Summary

For excluding PE (no further testing required): 1

  • Normal pulmonary angiogram
  • Negative highly sensitive D-dimer assay in low/intermediate probability patients
  • Normal perfusion lung scan
  • Normal MDCT alone in non-high clinical probability patients
  • Normal SDCT plus negative proximal CUS

For confirming PE (treatment warranted): 1

  • Pulmonary angiogram showing PE
  • High-probability V/Q scan
  • Proximal DVT on CUS
  • MDCT or SDCT showing PE at least at segmental level

Post-Diagnosis Risk Stratification

All patients with confirmed PE must be stratified by hemodynamic stability to identify high-risk patients with elevated early mortality. 4

  • Assess right ventricular function via imaging or biomarkers even in patients with low PESI/sPESI scores, as RV dysfunction affects early prognosis 4
  • The presence of proximal DVT on CUS increases risk of recurrent VTE in PE patients 1

Critical Pitfalls to Avoid

Failure to follow evidence-based diagnostic strategies when withholding anticoagulation despite clinical suspicion is associated with significantly increased VTE episodes and sudden death. 3

  • Never measure D-dimer in high clinical probability patients—it wastes time and can be falsely reassuring 2
  • Do not use MR angiography to rule out PE—it is not validated for this purpose 2
  • Avoid CT venography as an adjunct to CTPA—it adds no diagnostic value 2
  • Subsegmental PE on CT remains controversial and may require additional testing for confirmation 1
  • Overuse of CT imaging has led to increased diagnosis of less severe PEs without clear mortality benefit while exposing patients to radiation and contrast risks 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnóstico y Evaluación de Tromboembolia Pulmonar

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.